Inventor
RAUCH SUSANNE
DE22 patents
⚠️ This page may combine multiple inventors who share the name “RAUCH SUSANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CureVac SE
17 patentsUS11596686B2Mar 7, 2023
Coronavirus vaccine
CureVac SE16 citations94
US11576966B2Feb 14, 2023
Coronavirus vaccine
CureVac SE16 citations94
US11786590B2Oct 17, 2023
Rotavirus vaccines
CureVac SE5 citations86
US12168050B2Dec 17, 2024
Compositions comprising a norovirus nucleic acid and methods of use thereof
CureVac SE4 citations84
US11918643B2Mar 5, 2024
RNA vaccine against SARS-CoV-2 variants
CureVac SE6 citations81
US12318444B2Jun 3, 2025
Rotavirus vaccines
CureVac SE1 citations75
US12194089B2Jan 14, 2025
Coronavirus vaccine
CureVac SE1 citations74
US11964012B2Apr 23, 2024
Coronavirus vaccine
CureVac SE2 citations72
US11872280B2Jan 16, 2024
RNA vaccine against SARS-CoV-2 variants
CureVac SE5 citations70
US12390523B2Aug 19, 2025
Coronavirus vaccine
CureVac SE0 citations62
US11964011B2Apr 23, 2024
Coronavirus vaccine
CureVac SE0 citations62
US11865084B2Jan 9, 2024
MERS coronavirus vaccine
CureVac SE0 citations62
US12527856B2Jan 20, 2026
Artificial RNA molecules encoding a norovirus antigen and uses thereof
CureVac SE0 citations61
US12514918B2Jan 6, 2026
Nucleic acid molecules and uses thereof
CureVac SE0 citations61
US12350330B2Jul 8, 2025
RSV RNA molecules and compositions for vaccination
CureVac SE0 citations59
US12097253B2Sep 24, 2024
RSV RNA molecules and compositions for vaccination
CureVac SE1 citations59
US12508308B2Dec 30, 2025
Influenza mRNA vaccines
CureVac SE0 citations50
CUREVAC AG
5 patentsUS11241493B2Feb 8, 2022
Coronavirus vaccine
CUREVAC AG54 citations94
US11141476B2Oct 12, 2021
MERS coronavirus vaccine
CUREVAC AG29 citations94
US11471525B2Oct 18, 2022
Coronavirus vaccine
CUREVAC AG18 citations93
US11141474B2Oct 12, 2021
Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof
CUREVAC AG31 citations92
US11413346B2Aug 16, 2022
Rotavirus vaccines
CUREVAC AG12 citations86